Clinical application of biochemical modulation in cancer chemotherapy: Biochemical modulation for 5-FU

Oncology (Switzerland)

Volumn 54, Issue , 1997, Pages 12-18

  Taguchi, Tetsuo ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Modulation; Tegafur; UFT ; Uracil

Indexed keywords

FLUOROURACIL; PRODRUG; TEGAFUR; UFT; URACIL;

ANOREXIA; ANTINEOPLASTIC ACTIVITY; BIOCHEMISTRY; BLADDER CANCER; BLEEDING; BLOOD TOXICITY; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DIARRHEA; DRUG EFFICACY; DRUG METABOLISM; DRUG TUMOR LEVEL; GASTROINTESTINAL TOXICITY; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER DYSFUNCTION; LIVER TOXICITY; MALAISE; META ANALYSIS; METABOLIC ACTIVATION; NAUSEA; ORAL DRUG ADMINISTRATION; PIGMENT DISORDER; PRIORITY JOURNAL; SKIN TOXICITY; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DRUG COMBINATIONS; FLUOROURACIL; HUMANS; JAPAN; TEGAFUR; URACIL;

EID: 0031060360     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227740     Document Type: Article

References (20)

1. Hiller SA, Juk RA. Lidak MYU: Analogs of pyrimidine nucleosides. Dokl Akad Nauk SSSR 1967;176:332-335.
2. Fujii S, Ikenaka K, Fukushima M: Effect of Uracil and its derivatives on antitumor activity of 5-fluorouracil and l-(2-tetrahydrofuryl)-5-fluorouracil. Gann 1978;69:763-772.
3. Unemi N, Takeda S: Studies on combination therapy with l-(tetrahydro-2-furanyl)-5-fluoro-uracil plus Uracil. II. Effects of furacil on in vitro metabolisms of l-(tetrahydro-2-furanyl)-5-fluorouracil and 5-fluorouracil. Chemotherapy 1981;29:176-184.
4. Taguchi T, Nakano H, Jikuya H: Effect of Uracil on the antitumor activity of florafur. Jpn J Cancer Chcmother 1978;5:1161-1165.
5. Taguchi T, Furue H, Koyama Y, et al: Phase I study of UFT. Jpn J Cancer Chemother 1980: 7:966-972.
6. Nakajima O. Ihara K, Isoda T, et al: Phase 1 and II studies on mixture of l-(2-tetrahydrofu-ryl)-5-fluorouracil and Uracil. Jpn J Cancer Chemother 1980;7:1558-1568.
7. Kimura K, et al: Clinical bases of chemotherapy for gastric cancer with Uracil and l-(tetra-hydro-2-furanyl)-5-fluorouracil. Gastroenterol Jpn 1980;15:324-329.
8. Tsujimoto T, Sakai S, Murata M, et al: Concentrations of 5-FU in the tissue and scrum of patients with head and neck malignant tumors by preoperativc administration of UFT. Jpn J Cancer Chcmother 1983;10:78-83.
9. Suemasu K, Azuma Y, Nomoto M: Concentration of 5-FU level in the tissue and blood of patients with breast cancer by preoperative administration of UFT. Jpn J Cancer Chemothcr 1982;9:667-671.
10. Inuyama Y, Takeda C, Miyake H, et al: Phase II study for head and neck cancer. Jpn J Cancer Chemothcr 1985;12:479-484.
11. Ota K, Taguchi T, Kimura K: Report on nationwide pooled data and cohort investigation in UFT phase II study. Cancer Chemother Pharmacol 1988;22:333-338.
12. Naito K, Hisazumi H, Misaki T, et al: Clinical effect of UFT on prostatic cancer. Jpn J Cancer Chemother 1985;12:1440-1444.
13. Shida K, Yamanaka H, Ito Y, et al: Phase II study of UFT for malignant tumor of urinary organs. Jpn J Cancer Chemother 1984; 11: 1307-1314.
14. Noda K, Teshima K. Ikeda M, et al: UFT phase II study in cancer of uterine cervix. Jpn J Cancer Chemother 1985;12:900-906.
15. Tashiro H, Nomura Y, Ohsaki A: A doubleblind. comparative study of Tegafur (FT) and UFT (a combination of Tegafur and Uracil) in advanced breast cancer. Jpn J Clin Oncol 1994; 24:212-217.
16. Kurihara M, Izumi T, Yoshida S, et al: A comparative randomized study of Tegafur plus mitomycin C versus combined Tegafur and Uracil plus mitomycin C in the treatment of advanced gastric cancer. Jpn J Cancer Res 1991; 82:613-620.
17. Sato S, Hasegawa K, Kurihara M, et al: Combination chemotherapy with Tegafur-Uracil (UFT) and cisplatin (CDDP) for advanced gastric cancer. Jpn J Cancer Chemother 1995;22: 1355-1362.
18. Matsuki N, Sakuma H, Sawa T, et al: Effect of PMU therapy (CDDP, MMC and UFT) against terminal gastric cancer. Jpn J Cancer Chemother 1988;15:655-659.
19. Sawa T, Kinoshita K, Takebayashi S, et al: Effect of PMUE therapy (CDDP, MMC, UFT, ctoposide) for terminal gastric cancer. Jpn J Cancer Chemothcr 1990; 17:2381-2386.
20. Wada H, Hitomi S, Tcrcmatsu T, et al: Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. J Clin Oncol 1996; 14:1048-1054.